|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| A61K 31/444 | (2006.01) | ||
| A61P 25/06 | (2006.01) |
| (11) | Number of the document | 3551617 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17829372.6 |
| Date of filing the European patent application | 2017-12-05 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation | 2021-10-11 |
| (86) | Number | PCT/US2017/064652 |
| Date | 2017-12-05 |
| (87) | Number | WO 2018/106657 |
| Date | 2018-06-14 |
| (30) | Number | Date | Country code |
| 201662430662 P | 2016-12-06 | US |
| (72) |
ALLIERI, Brigida , US
FAGAN, Paul , US
SHARP, Emma , GB
SKWIERCZYNSKI, Raymond, D. , US
|
| (73) |
CoLucid Pharmaceuticals, Inc. ,
c/o Eli Lilly and Company
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, susiję su piridinoilpiperidino 5-HT1F agonistais |
| COMPOSITIONS AND METHODS RELATED TO PYRIDINOYLPIPERIDINE 5-HT1F AGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-11-19 | 9 | 208.00 EUR |
| 2026-12-05 |